Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR Tablet
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This study will be an open-label, randomised, four-period, four-treatment, crossover study in
healthy male and female of non-childbearing potential subjects, performed at a single study
centre.
The objective of the study is to assess the bioavailability of ticagrelor orodispersible (OD)
tablets when administered with water, without water and suspended in water to be administered
through nasogastric tubes, compared to ticagrelor immediate-release (IR) tablets